Abstract
Postoperative long-term cancer chemotherapy (PLCC) with a combination of Mitomycin-C, Tegafur and PSK (an immunostimulant) was applied to non-curatively resected cases with stage IV gastric cancer (invading the adjacent organs and/or with metastasis to the liver, peritoneum, and/or distant lymph nodes). This approach has a significant life-prolongation effect. The two-year survival rate was 16.8 per cent in the PLCC group, such being higher than 6.7 per cent and 1.7 per cent in MMC and no chemotherapy groups (p<0.05). 50 per cent survival periods in those with liver metastasis were 8.3 months in the PLCC group, such being longer than 5.2 and 2.8 months in MMC and no chemotherapy groups (p<0.002) respectively. Combination therapy of PLCC and intra-arterial infusion of 5-FU through the proper hepatic artery prescribed for 8 patients with liver metastasis resulted in a 3-month prolongation of 50 per cent survival periods, compared with PLCC alone (p<0.05). In those with peritoneal dissemination the rate was 10.5 months in the PLCC group, that is longer than 6.5 months in the MMC group (p<0.02). In cases of invasion to other organs plus distant lymph node metastasis, the time was 11.0 in PLCC and 7.0 months in MMC groups (p<0.05). Thus, PLCC is a palliative approach for non-curatively resected carcinoma of the stomach.
Similar content being viewed by others
References
Kodama, Y., Sugimachi, K., Soejima, K., Matsusaka, T. and Inokuchi, K.: Evaluation of extensive lymph node dissection for carcinoma of stomach. World J. Surg. 5: 241–248, 1981.
Kaibara, N., Soejima K., Nakamura, T. and Inokuchi, K.: Adjuvant chemotherapy for gastric cancer patients receiving incurable gastrectomy. J. Clin. Surg. 31: 1139–1143, 1976.
Kano, T., Kumashiro, R., Tamada, R., Kodama, Y. and Inokuchi, K.: Late results of postoperative long-term cancer chemotherapy for advanced carcinoma of the stomach. Jpn. J. Surg. 11: 291–296, 1981.
Japanese Research Society for Gastric Cancer: The General Rules for the Gastric Cancer Study in Surgery. Jpn. J. Surg. 3: 61–71, 1973.
Nakajima, S., Kinoshita, I., Kasumi, F., Mori, M., Izumoi, I. and Fukami, A.: Adjuvant chemotherapy for gastric cancer in cases of noncurative operation. Jpn. J. Cancer Clin. 20: 392–396, 1974.
Higgins, G.A.: Chemotherapy in advanced gastric cancer in Gastric Cancer edited by Ch. Herforth and P. Schlag: 361–366, Spring-Verlag, Berlin, Heidelberg, New York, 1979.
Kovach, J.S., Moertel, C.G., Schutt, A.J., Hahn, R.G. and Reitemeier, R.J.: A controlled study of combined 1, 3-bis-(2-chloroethyl)-1-nitrosourea and 5-fluorouracil therapy for advanced gastric and pancreatic cancer. Cancer 33: 563–567, 1974.
The gastrointestinal tumor group: Phase II–III chemotherapy studies in advanced gastric cancer. Cancer Treatment Reports 63: 1871–1876, 1979.
Furue, H., Furukawa, K., Kanko, T., Nakao, I. and Yokoyama, T.: Clinical aspects of cancer chemotherapy in advanced gastric cancer. J. Clin. Surg. 31: 1145–1150, 1976.
Mayer, M.: A controlled prospective study of adjuvant 5-fluorouracil and BCNU therapy in stomach carcinoma in Gastric Cancer edited by Ch. Herforth and P. Schlag: 357–360, Springer-Verlag, Berlin, Heidelberg, New York, 1979.
Kano, T., Abe, Y., Hiramoto, Y., Inoue, F., Shiraishi, M., Tamada, R., Kumashiro, R., Kodama, Y. and Inokuchi, K.: Effect of postoperative long-term cancer chemotherapy (PLCC) on gastric cancer patients with peritoneal dissemination. Cancer & Chemotherapy 8: 1418–1424, 1981.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kano, T., Tamada, R., Abe, Y. et al. Postoperative long-term cancer chemotherapy (PLCC) extends life-span of non-curatively resected patients with stage IV gastric cancer. The Japanese Journal of Surgery 12, 203–207 (1982). https://doi.org/10.1007/BF02469588
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02469588